Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal
Constance Ducar(Fred Hutch Cancer Center), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Cris Pinzon(Infectious Disease Research Institute), M. Juliana McElrath(Fred Hutch Cancer Center), Donna Smith(Infectious Disease Research Institute), Cristine J. Cooper(Fred Hutch Cancer Center), Michael Stirewalt(Infectious Disease Research Institute)
Cited by 24
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
|New England Journal of Medicine|2013|586
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557